Man just hit the wire jump in!!!
United Health Products and Patterson/Animal Health International Launch Nationwide Marketing Campaign for HemoStyp(R) Products to U.S. Veterinary Healthcare MarketFont size: A | A | A
8:40 AM ET 8/28/17 | Dow Jones
United Health Products and Patterson/Animal Health International Launch Nationwide Marketing Campaign for HemoStyp(R) Products to U.S. Veterinary Healthcare Market
HENDERSON, Nev., Aug. 28, 2017 (GLOBE NEWSWIRE) -- United Health Products, Inc. (OTC:UEEC), a manufacturer and marketer of HemoStyp, a patented hemostatic gauze for the healthcare and wound care sectors, today announced that, in conjunction with Patterson Veterinary/Animal Health International, Inc. (AHI), a subsidiary of Patterson Companies, Inc., it will conduct a marketing campaign to more than 8,000 companion animal clinics in the United States.
Patterson Veterinary/AHI, United Health Products' exclusive distributor to the U.S. animal health market, with a sales force more than 400 strong, will officially launch the campaign on September 1, which will last until year end 2017. The campaign's objective is to significantly increase sales of four HemoStyp products to the $10 Billion domestic veterinary healthcare market, and to attain major market share gains in that market, one of the five that United Health Products serves.
"We expect the marketing campaign with Patterson Veterinary/AHI to lead to significant sales in the third and fourth quarter of this year," said Douglas K. Beplate, CEO. "Patterson Veterinary/AHI is one of the largest animal health companies in the United States, and we have been working diligently with them to make this program a success. Additional incentives to customers, coupled with our already leading cost effective pricing, should enable us to expand our footprint in this rapidly growing market."
About Patterson Veterinary/Animal Health International
Recent UEEC News
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 08/20/2024 04:52:34 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2024 06:00:59 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 07/30/2024 04:15:05 AM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 07/25/2024 06:47:51 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 07/22/2024 06:38:26 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 07/15/2024 05:36:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 08:16:02 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 10:05:42 PM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM